Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer

R. M. Subramaniam, M. Truong, P. Peller, O. Sakai, G. Mercier

Research output: Contribution to journalReview article

Abstract

The hybrid technique of PET/CT has significantly impacted the imaging and management of HNSCC since its introduction in 2001 and has become the technique of choice for imaging of this cancer. Diagnostic FDG-PET/CT is useful for identification of an unknown primary tumor, delineation of extent of primary tumor, detection of regional lymph node involvement even in a normal-sized node, detection of distant metastases and occasional synchronous primary tumor, assessment of therapy response, and long-term surveillance for recurrence and metastases. The role of PET/CT is evolving in radiation therapy planning. Combined diagnostic PET/CT provides the best anatomic and metabolic in vivo information for the comprehensive management of HNSCC.

Original languageEnglish (US)
Pages (from-to)598-604
Number of pages7
JournalAmerican Journal of Neuroradiology
Volume31
Issue number4
DOIs
StatePublished - Apr 1 2010

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer'. Together they form a unique fingerprint.

  • Cite this